A new study found that the BRCA1 and BRCA2 genetic mutations that lead to a hereditary predisposition for breast cancer are also associated with a 10-fold increase in the possibility of getting ovarian cancer. The study, underwritten by the genetic testing company Myriad, was published in the July issue of the Journal of Clinical Oncology. The mutations are found more often among Ashkenazi Jews than in the rest of the population.
JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent, award-winning reporting.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
